Workers’ Strikes in Vietnam from a Regulatory Perspective
Sign Up to like & getrecommendations! Published in 2017 at "Asian Studies Review"
DOI: 10.1080/10357823.2017.1298568
Abstract: Abstract The persistence of factory strikes in Vietnam has strained the country’s industrial relations system. This paper examines workers’ strikes from a regulatory perspective to evaluate the effects and limitations of labour law in establishing… read more here.
Keywords: law; regulatory perspective; strikes vietnam; vietnam regulatory ... See more keywords
Barriers to and enablers of Pakistani pharmaceutical export to regulated markets: regulatory perspective
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Pharmaceutical Policy and Practice"
DOI: 10.1080/20523211.2025.2564828
Abstract: ABSTRACT Background The pharmaceutical sector in Pakistan has grown over a period; however, there are certain barriers within the framework that regulate the growth and export of pharmaceuticals in the country. The purpose of this… read more here.
Keywords: pakistani pharmaceutical; barriers enablers; development; enablers pakistani ... See more keywords
D-Penicillamine: The State of the Art in Humans and in Dogs from a Pharmacological and Regulatory Perspective
Sign Up to like & getrecommendations! Published in 2021 at "Antibiotics"
DOI: 10.3390/antibiotics10060648
Abstract: Chelant agents are the mainstay of treatment in copper-associated hepatitis in humans, where D-penicillamine is the chelant agent of first choice. In veterinary medicine, the use of D-penicillamine has increased with the recent recognition of… read more here.
Keywords: medicine; regulatory perspective; humans dogs; copper associated ... See more keywords
A Regulatory Perspective on Biosimilar Medicines
Sign Up to like & getrecommendations! Published in 2024 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics16030321
Abstract: By definition, biosimilar medicinal products are biological medicinal products that are similar to other biological medicinal products that are already on the market—the reference medicinal products. Access to biosimilar medicines is a current reality. However,… read more here.
Keywords: market; biosimilar medicines; perspective biosimilar; medicinal products ... See more keywords